SAS Output

18-JUN-2018 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 180 21 11 5 2 1 0 07/25/2016 225 96
        2 Cabozantinib   22 13 8 5 2 1      
        3 Crizotinib   22 12 6 3 1 1      
        4 Savolitinib   22 11 7 3 0 0      
            87 47 26 13 4 2      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 36 32 17 9 0 0 02/24/2017 154 74
        2 Tokyo-172 BCG   37 34 18 12 4 1      
        3 Prime + Tokyo-172 BCG   38 35 19 13 4 1      
            111 101 54 34 8 2      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 148 51 46 26 14 3 0 03/13/2017 160 71
            51 46 26 14 3 0      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   3 1 1 0 0 0 11/23/2016 66 35
            3 1 1 0 0 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   16 16 10 6 1 0 09/29/2017   123
            16 16 10 6 1 0      
 
    1 E Total Registrations   12 12 7 5 1 0 09/29/2017    
            12 12 7 5 1 0      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   1 1 0 0 0 0 08/24/2017   125
            1 1 0 0 0 0      
 
    2 E Total Registrations   1 1 0 0 0 0 08/24/2017    
            1 1 0 0 0 0      
 
No A031501-Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 E Total Registrations   3 3 3 3 2 0 05/03/2018   14
            3 3 3 3 2 0      
 
    1 E Total Registrations   1 1 1 1 1 1 05/03/2018    
            1 1 1 1 1 1      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   79 33 19 8 3 0 11/25/2013   175
            79 33 19 8 3 0